Inactive Instrument
Guided Therapeutics Inc Share Price OTC Bulletin Board
Stocks
US40171F2048
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 06-16 | Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA | CI |
| 05-15 | Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 28.96M 25.33M 23.37M 21.58M 40.95M 2.76B 41.64M 279M 110M 1.36B 109M 106M 4.68B | P/E 2024 |
-3x | P/E 2025 | -12.7x |
|---|---|---|---|---|---|
| Enterprise Value | 31.84M 27.85M 25.69M 23.72M 45.02M 3.04B 45.77M 307M 121M 1.5B 120M 117M 5.14B | EV / Sales 2024 |
1,649x | EV / Sales 2025 | 64.4x |
| Free-Float |
63.48% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 70 | 05/03/2023 |
| Chief Tech/Sci/R&D Officer | 70 | 01/12/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Faupel
BRD | Director/Board Member | 70 | 30/11/2016 |
John Imhoff
BRD | Director/Board Member | 76 | 09/04/2006 |
Michael James
CHM | Chairman | 67 | 30/09/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.45% | +0.69% | +21.20% | +0.21% | 196B | ||
| -1.16% | -4.51% | -20.56% | +17.03% | 144B | ||
| +1.57% | +0.57% | -2.83% | -16.40% | 141B | ||
| -0.49% | -0.82% | -56.62% | -14.66% | 66.54B | ||
| +0.96% | -2.29% | +18.14% | -0.96% | 53.09B | ||
| +0.61% | -1.09% | -24.93% | -31.31% | 44.12B | ||
| +0.52% | +2.75% | +8.93% | +11.91% | 37.93B | ||
| -0.19% | -0.75% | +6.66% | +39.97% | 36.96B | ||
| 0.00% | -1.32% | -13.88% | -20.80% | 29.43B | ||
| Average | +0.25% | -0.75% | -7.10% | -1.67% | 83.21B | |
| Weighted average by Cap. | +0.27% | -0.83% | -3.92% | -1.21% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7K 6.12K 5.65K 5.22K 9.9K 668K 10.06K 67.48K 26.5K 329K 26.28K 25.71K 1.13M | 767K 671K 619K 572K 1.08M 73.15M 1.1M 7.39M 2.9M 36.04M 2.88M 2.82M 124M |
| Net income | -2.42M -2.11M -1.95M -1.8M -3.42M -231M -3.47M -23.3M -9.15M -114M -9.08M -8.88M -390M | -3.2M -2.8M -2.58M -2.38M -4.52M -305M -4.59M -30.81M -12.1M -150M -12M -11.74M -516M |
| Net Debt | 1.77M 1.55M 1.43M 1.32M 2.5M 169M 2.55M 17.07M 6.7M 83.21M 6.65M 6.5M 286M | 2.88M 2.52M 2.32M 2.14M 4.07M 274M 4.13M 27.72M 10.89M 135M 10.8M 10.56M 465M |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















